FRES - fresh2.co Uzoq muddatli majburiyatlarning kapitalga nisbati

Fresh2 Group (FRES) kompaniyasining korporativ logotipi

Fresh2 Group Limited (FRES) narxlar grafigi Osiyo texnologik gigantlari bilan qattiq raqobat va past brokerlik marjalari sharoitida faoliyat yuritayotgan kompaniyaning dinamikasini aks ettiradi. Biznes Xitoyning agro-IT segmentiga tayanadi, u yerda moliyaviy barqarorlik tartibga soluvchi bosim va beqaror talab tufayli cheklangan bo'lib, ko'rsatkich 0.00 darajasida turibdi. Oziq-ovqat sanoati uchun B2B platformasini kengaytirishga qaratilgan harakatlar marketing va yetkazib berish xarajatlarining ortishi tufayli to'siqlarga duch kelmoqda.

Fresh2 (FRES): Uzoq muddatli qarzning kapitalga nisbati 21.02.2024dan 04.01.2025gacha
Fresh2 Group Ltd asosiy tovari

AQSH va Xitoyda raqamli B2B logistikasini rivojlantirayotgan Fresh2 Group Limited uchun qarzdorlikning kapitalga nisbati uning uzoq muddatli infratuzilma moliyalashtirish strategiyasini aks ettiradi. Ushbu ko'rsatkich uzoq muddatli majburiyatlarni aksiyadorlarning sof aktivlari bilan solishtiradi. Ushbu nisbatning oshishi biznesni kengaytirish uchun leverajning ortganligidan dalolat beradi. Ushbu nisbatning kamayishi moliyaviy barqarorlikni tasdiqlaydi. Investorlar hamyonbop qarz va to'lov qobiliyati risklari o'rtasidagi muvozanatni baholashlari lozim.

Fresh2 Group Limited kimlar bilan raqobatlashadi

Uzoq muddatli qarzning o'z kapitaliga nisbati Agilent Technologies, Inc.|Quest - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Illumina Platform (ILMN)|EXAS - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi revvity.com RVTY|Bio-Rad - Uzoq muddatli qarzning kapitalga nisbati|NNNN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Sterigenics|QuidelOrtho Inc. (QDEL) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|OPK (OPKO Health, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati CDNA|Uzoq muddatli qarzning o'z kapitaliga nisbati Maravai LifeSciences Holdings, Inc. (MRVI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Fulgent Genetics Inc FLGT|LAB: Uzoq muddatli qarzning o'z kapitaliga nisbati|Cytek Corp - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati OSUR (OraSure Technologies)|XGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|MDxHealth - Uzoq muddatli qarzning kapitalga nisbati|LUCD (Lucid Diagnostics, Inc.) - Uzoq muddatli qarzdorlikning kapitalga nisbati|PRE: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Insight Molecular|TRIB - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PRPH (prophaselabs.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ainos|Uzoq muddatli qarzning kapitalga koeffitsiyenti Co-Diagnostics Inc CODX|HSCS (Heart Test Laboratories Inc.) - Uzoq muddatli qarzning kapitalga nisbati|BMRA: Uzoq muddatli majburiyatlarning kapitalga nisbati|cardiodiagnosticsinc.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|viraxbiolabs.com (VRAX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|BJDX - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AWH|Uzoq muddatli qarzning o'z kapitaliga nisbati AXDX (Accelerate Diagnostics, Inc)|CNTG (Centogene) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ENZ (Enzo Biochem)|Uzoq muddatli qarzning kapitalga nisbati Genetic Technologies Ltd|ME - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PMD (Psychemedics Corp.)